Which liquid biopsy analytes have the highest potential for improved patient stratification in clinical trials within the next 5 years?

Vote below
112 votes
Cell-free DNA
46%
72 votes
Circulating tumor cells
30%
28 votes
Exosomes / extracellular vesicles
12%
11 votes
Cell-free RNA / miRNA
5%
20 votes
Multiple analytes
8%